Last reviewed · How we verify

NCT03551041

The Neural Representation of Self in Depression Patients

Completed Last updated 11 June 2018
What this trial tests

trial in Depression Disorder in 23 participants. Completed in 26 January 2018.

Timeline
27 May 2014
Primary endpoint
15 June 2017
26 January 2018

Quick facts

Lead sponsorBeijing Normal University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment23
Start date27 May 2014
Primary completion15 June 2017
Estimated completion26 January 2018

Conditions studied

Sponsor

Beijing Normal University

Who can join

Adults 18 to 60, any sex, with Depression Disorder or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To be aware of oneself as a unique entity in the world occurs early in human development and is the prerequisite of normal social functioning. The disturbance of self representation characterizes a variety of mental disorders such as autism and schizophrenia. Negative self-bias was found to serve as the core cognitive mechanism of depression disorder. However, there was no evidence to show the reason lead to negative bias. In the current study, investigators hypothesized that the blurring self representation was the neural correlates in depression disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Depression Disorder

Currently open trials in the same condition.

Other Beijing Normal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing